NCT07668518
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD
레지스트리 요약
- 진행 상태
- 모집중 (RECRUITING)
- 질환/조건
- Chronic Obstructive Pulmonary Disease (COPD)
- 시험 유형
- 중재 연구 (INTERVENTIONAL)
- 단계
- Phase 1, Phase 2
- 목적
- 치료
- 중재 유형
- 약물
- 개입·치료
- KIT2014, Placebo
- Lead Sponsor
- Kither Biotech Srl (산업계)
캐시 시각: 2026-09-10 09:07:52
요약
Study investigating the safety, tolerability, pharmacokinetics and early efficacy with KIT2014 over 7 days of treatment in moderate to severe chronic obstructive pulmonary disease patients.
